Cargando…
Targeted therapy in melanoma
Malignant melanoma is a highly lethal disease unless detected early. Single-agent chemotherapy is well tolerated but is associated with very low response rates. Combination chemotherapy and biochemotherapy may improve objective response rates but do not prolong survival and are associated with great...
Autores principales: | Tawbi, Hussein, Nimmagadda, Neelima |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802073/ https://www.ncbi.nlm.nih.gov/pubmed/20054438 |
Ejemplares similares
-
The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition
por: Kreidieh, Firas Y., et al.
Publicado: (2023) -
Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma
por: ERIKSSON, Hanna, et al.
Publicado: (2020) -
Targeted Therapy and Immunotherapy Response Assessment with F-18 Fluorothymidine Positron-Emission Tomography/Magnetic Resonance Imaging in Melanoma Brain Metastasis: A Pilot Study
por: Nguyen, Nghi C., et al.
Publicado: (2018) -
Melanogenesis and the Targeted Therapy of Melanoma
por: Li, Cang, et al.
Publicado: (2022) -
Safe and effective administration of T-VEC in a patient with heart transplantation and recurrent locally advanced melanoma
por: Schvartsman, Gustavo, et al.
Publicado: (2017)